ResMed (RMD) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.95 -0.5%
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +6.9%
Financial Fact:
Total operating expenses: 175.04M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $0.69, $0.03 better than the analyst estimate of $0.66. Revenue for the quarter came in at $454.5 million versus the consensus estimate of $446.25 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Sunbelt Rentals Holdings, Inc. (SUNB) Reports Q2 EPS of $1.18
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
